Bacteroides fragilis prevents aging-related atrial fibrillation in rats via regulatory T cells-mediated regulation of inflammation. (March 2022)

• Record Type: Journal Article
• Authors: Zhang, Yun; Sun, Danghui; Zhao, Xinbo; Luo, Yingchun; Yu, Hui; Zhou, Yun; Gao, Yunlong; Han, Xuejie; Duan, Yu; Fang, Ning; Duan, Xiaoxu; Li, Tiankai; Zhang, Song; Gong, Yongtai; Li, Yue
• Is Part Of: Pharmacological research. Volume 177(2022)
• Publication Date: 2022-03
• Subjects: AF atrial fibrillation -- CVF Collagen volume fraction -- OTUs Operational taxonomic units -- PSA Polysaccharide A -- qRT-PCR Quantitative real-time polymerase chain reaction -- ROC Receiver operating curve -- SR Sinus rhythm -- TMAO trimethylamine N-oxide -- Treg regulatory T cells; Aging -- Atrial fibrillation -- Gut microbes -- Atrial remodeling -- Inflammation; Pharmacology -- Periodicals; Pharmacology -- Periodicals; Research -- Periodicals; Médicaments -- Recherche -- Périodiques; Pharmacologie -- Périodiques; 615.105
• DOI: 10.1016/j.phrs.2022.106141
• Languages: English
• ISSNs: 1043-6618

Abstract

Abstract: Background: Aging plays a critical role in the genesis of atrial fibrillation (AF) and also changes the gut microbes. Whether the aging-associated gut dysbiosis contributes to the development of aging-related AF and whether the gut microbes can be a target to prevent aging-related AF remains unknown. Methods and results: 16S rRNA gene sequencing was performed to reveal the changes of gut microbes in elderly patients with AF, and the result showed that the intestinal abundance of B. fragilis was significantly decreased in elderly patients with AF. Subsequently, we examined the impact of B. fragilis supplementation on AF promotion, atrial structural remodeling and inflammation response in D -galactose induced aging rats. We found that oral administration of B. fragilis prevented AF inducibility and duration, which was associated with attenuation of atrial senescence, apoptosis and fibrosis. Furthermore, B. fragilis significantly diminished the systemic and atrial inflammation, which is accompanied by an increase in the number of Treg cells in the spleen and blood. More importantly, we found that the circulation level of polysaccharide A (PSA), the metabolite synthesized by B. fragilis, was reduced in elderly patients with AF and could predict the occurrence of AF, and B. fragilis increased the circulation concentration of PSA in D -galactose induced aging rats. Conclusions: The abundance of B. fragilis was lower in elderly patients with AF. Oral administration of B. fragilis significantly attenuated inflammatory response by increasing Treg cells, thereby preventing atrial structural remodeling and inhibiting AF promotion in D -galactose induced aging rats. This study provides experimental evidence for the effectiveness of targeting gut microbes in the prevention of aging-related AF. Graphical Abstract: ga1